Axon Therapies

New York, United States

Axon Therapies develops a healthcare device with a neuromodulation approach to treat heart failure.

$32.0M raised

Sep 2025

Series A

Health Care Neuroscience Travel

Top Investors

Sante VenturesDeerfieldEarlybird Venture CapitalAction Potential Venture CapitalKOFA Healthcare

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Axon Therapies

How much funding has Axon Therapies raised?

Axon Therapies has raised $32.0M in total funding. The most recent round was Series A. The last funding was announced in September 2025.

Who are Axon Therapies's investors?

Axon Therapies's investors include Sante Ventures, Deerfield, Earlybird Venture Capital, Action Potential Venture Capital, KOFA Healthcare.

Where is Axon Therapies headquartered?

Axon Therapies is headquartered in New York, United States.

What does Axon Therapies do?

Axon Therapies develops a healthcare device with a neuromodulation approach to treat heart failure.

What stage is Axon Therapies at?

Axon Therapies is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 25, 2025.

MLA

"Axon Therapies — Funding & Investors." VCBacked, September 25, 2025, https://www.vcbacked.co/company/axon-therapies. Accessed June 23, 2026.

APA

VCBacked. (2025). Axon Therapies — Funding & Investors. Retrieved June 23, 2026, from https://www.vcbacked.co/company/axon-therapies

Wikipedia (cite web)

{{cite web |title=Axon Therapies — Funding & Investors |url=https://www.vcbacked.co/company/axon-therapies |website=VCBacked |access-date=June 23, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 25, 2025.

Similar Companies in Health Care